How to identify, protect and exploit the data you already haveRead more
Diversification, collaboration and consolidation are likely to be emerging themes in the cell and gene therapies (CGTs) market globally in 2023 and beyond, as developers seek to make their businesses resilient to the economic headwinds they face.Life Sciences & Health
Pinsent Masons advises PIC on £132m buy-in of Tomkins 2008 pension scheme retirement benefits plan.
Multinational law firm Pinsent Masons has advised various institutional investors in relation to Umicore’s € 591 million sustainability linked note fundraising.
Pinsent Masons has advised the shareholders of Alveo, including funds managed by Sovereign Capital Partners (SCP), on its sale to Symphony Technology Group (STG).